InvestSMART

Wellnex Life Limited (ASX: WNX) - Announcements

- Current share price for WNX : $0.079

ASX company news and announcements for Wellnex Life Limited (WNX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Wellnex Life Limited (WNX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Wellnex Life Limited (WNX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Wellnex Life Limited (WNX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$6 Change in substantial holding 28 Mar 2022 9:05AM $0.130 $0.079 fallen by 39.23%
$6 Appendix 3Y - Kobe Li 24 Mar 2022 10:21AM $0.125 $0.079 fallen by 36.80%
$6 Appendix 3Y - George Karafotias 24 Mar 2022 9:30AM $0.125 $0.079 fallen by 36.80%
$6 Appendix 3Y - Zack Bozinovski 24 Mar 2022 9:30AM $0.125 $0.079 fallen by 36.80%
$6 Notification regarding unquoted securities - WNX 22 Mar 2022 12:29PM $0.115 $0.079 fallen by 31.30%
$6 Wellnex Life Signs Supple Agreement with GSK 18 Mar 2022 8:39AM $0.082 $0.079 fallen by 3.66%
$6 Investor Presentation 17 Mar 2022 10:01AM $0.082 $0.079 fallen by 3.66%
$6 Trading Halt 17 Mar 2022 9:45AM $0.082 $0.079 fallen by 3.66%
$6 Wellnex Life Releases Half Year Report 28 Feb 2022 10:01AM $0.110 $0.079 fallen by 28.18%
$6 Half Yearly Report and Accounts 28 Feb 2022 9:58AM $0.110 $0.079 fallen by 28.18%
$6 AHF: JV with WNX to Launch Organic A2 Infant Formula Range 16 Feb 2022 11:21AM $0.120 $0.079 fallen by 34.17%
$6 JV with AHF to Launch Organic A2 Infant Formula Range 16 Feb 2022 8:39AM $0.110 $0.079 fallen by 28.18%
$6 Appendix 4C and Quarterly Report for Dec 2021 Quarter 31 Jan 2022 9:41AM $0.105 $0.079 fallen by 24.76%
$6 Constitution 24 Jan 2022 5:18PM $0.099 $0.079 fallen by 20.20%
$6 Results of Meeting 24 Jan 2022 5:04PM $0.099 $0.079 fallen by 20.20%
$6 AGM CEO Address 24 Jan 2022 9:16AM $0.097 $0.079 fallen by 18.56%
$6 Half Year Company Financial Update 7 Jan 2022 9:38AM $0.098 $0.079 fallen by 19.39%
$6 Notice of Annual General Meeting/Proxy Form 23 Dec 2021 8:19AM $0.094 $0.079 fallen by 15.96%
$6 Company Update 17 Dec 2021 8:22AM $0.110 $0.079 fallen by 28.18%
$6 Wellnex Launches Pharmacy Own with CH2 14 Dec 2021 9:56AM $0.091 $0.079 fallen by 13.19%
$6 Wellnex Enters into JV with Australian Dairy Nutritionals 9 Dec 2021 10:10AM $0.082 $0.079 fallen by 3.66%
$6 Change of Company Registered Office 15 Nov 2021 4:15PM $0.100 $0.079 fallen by 21%
$6 Appendix 4C and Quarterly Report for Sep 2021 Quarter 29 Oct 2021 8:18AM $0.110 $0.079 fallen by 28.18%
$6 Ranging in Chemist Warehouse for Performance Inspired 1 Oct 2021 9:47AM $0.098 $0.079 fallen by 19.39%
$6 Notification regarding unquoted securities - WNX 30 Sep 2021 9:49AM $0.100 $0.079 fallen by 21%

401 - 425 of 454 results

Page 17 of 19

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.